A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
NCT00349492
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
372
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
DRUG:
IP
Sponsor
Clinical Research Center for Solid Tumor, Korea